Clinical trial Recruiting at 1 site Interventional Ages 45 to 75

TENS plus controlled heat to increase blood flow in the foot

Official title: Principle Investigator

Run by Western Michigan University · NCT07063524 · Data updated 2026-11-12

Try using gentle electrical stimulation (TENS) together with controlled heat in a boot to see if it increases blood flow to the foot in adults with diabetes.

More Diabetes trials

Quick facts

Study typeInterventional
Ages45 Years to 75 Years
SexAll
Enrollment20 (estimated)
SponsorWestern Michigan University
Academic / other
Locations1 site (Kalamazoo, Michigan)
StatusRecruiting
StartedMay 10, 2024
Main results expectedDecember 30, 2025
Study endsDecember 30, 2025
Registry record updatedJuly 14, 2025
Trial IDNCT07063524 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45–75 with well-controlled Type 1 or Type 2 diabetes (HbA1c ≤ 7%), without neuropathy or major cardiovascular/pulmonary disease, who can tolerate wearing a boot for about 60 minutes.

Probably not a fit

People with uncontrolled diabetes, diagnosed neuropathy, pacemakers, severe cardiovascular or pulmonary disease, active skin conditions, current smokers, pregnant people, or those unable to wear the boot are unlikely to qualify or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This protocol measures short-term changes in foot blood flow when participants wear a heated boot with and without transcutaneous electrical nerve stimulation (TENS). Participants rest while baseline temperature, SpO2, and heart rate are recorded, then a pulse oximeter and a PPG sensor embedded in an insole record perfusion during each condition. Blood flow is recorded for short (five-minute) periods to compare baseline, heat alone, and heat plus TENS within the same individual. The procedure is noninvasive and performed as a single outpatient visit.

Why it matters

Potential benefit: If successful, the combination could improve foot circulation and help heal or prevent diabetic foot wounds.

How similar studies have gone: Prior small studies show that local heating and TENS can separately increase peripheral blood flow, but combining TENS with a controlled heated boot is a relatively novel approach with limited direct evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or Female aged between 45-75 years old
* Clinical diagnosis of Type I or Type II diabetes
* Controlled diabetes mellitus (HbA1c ≤ 7%)

Exclusion Criteria:

* Pregnancy
* Current smoker
* Diagnosed neuropathy
* Uncontrolled hypertension (HTN)
* Allergy to tape or electrodes
* Diagnosis of dementia
* History of knee joint replacement
* Significant joint pain (e.g., back, hip, or ankle) that may limit the ability to wear a boot for 60 minutes
* Contraindications to TENS, including:

  * Presence of pacemakers
  * Dermatological conditions
  * Abnormal sensation in the knees
* Severe medical or neurological conditions, including:

  * Chronic obstructive pulmonary disease
  * Cardiovascular disease
  * Arteriosclerosis obliterans
  * Cerebrovascular accident
  * Lumbar disc disorders (e.g., herniation)
  * Rheumatoid arthritis
* Fear of electrical stimulation

Where it's running

  • Western Michigan University
    Kalamazoo, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.